THE PROTEASOME-ASSOCIATED DEUBIQUITINASE PSMD14 AS A POTENIAL NOVEL ANTI-CANCER THERAPEUTIC TARGET

被引：0
|
作者：
Messmer, Clemence [1 ]
Menggad, Saad [1 ]
Barbour, Haithem [1 ]
Daou, Salima [1 ]
Sen, Nadine [1 ]
Boutayeb, Achraf [1 ]
Masclef, Louis [1 ]
Ahmed, Oumaima [1 ]
Rouette, Alexandre [2 ]
Meloche, Sylvain [2 ]
Perreault, Claude [2 ]
Affar, El Bachir [1 ]
机构：
[1] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ, Canada
[2] Inst Rech Immunol & Cancerol, Montreal, PQ, Canada
来源：
PROTEIN SCIENCE | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
405
引用
收藏
页码：150 / 151
页数：2
相关论文
共 50 条
  • [31] Mitochondrial complex II, a novel target for anti-cancer agents
    Kluckova, Katarina
    Bezawork-Geleta, Ayanachew
    Rohlena, Jakub
    Dong, Lanfeng
    Neuzil, Jiri
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2013, 1827 (05): : 552 - 564
  • [32] A novel TLR agonist as a potent anti-cancer therapeutic agent
    Petschenka, J.
    Vascotto, F.
    Walzer, K. C.
    Roth, R.
    Koenig, A.
    Ettingshausen, C.
    Brkic, M.
    Krimmel, N.
    Beulshausen, I.
    Schmitt, U.
    Vormehr, M.
    Roesemann, R.
    Diken, M.
    Kreiter, S.
    Strobl, S.
    Tuereci, Z.
    Sahin, U.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 11 - 11
  • [33] POH1/Rpn11/PSMD14: a journey from basic research in fission yeast to a prognostic marker and a druggable target in cancer cells
    Vito Spataro
    Antoine Buetti-Dinh
    British Journal of Cancer, 2022, 127 : 788 - 799
  • [34] Profound Activity of the Anti-cancer Drug Bortezomib against Echinococcus multilocularis Metacestodes Identifies the Proteasome as a Novel Drug Target for Cestodes
    Stadelmann, Britta
    Aeschbacher, Denise
    Huber, Cristina
    Spiliotis, Markus
    Mueller, Joachim
    Hemphill, Andrew
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (12):
  • [35] Exosomal miR-6126 as a novel therapeutic target for overcoming resistance of anti-cancer effect in hepatocellular carcinoma
    Hwang, Hyemin
    Kim, Jimin
    Kim, Tae-Hun
    Han, Yeonju
    Choi, Dayoung
    Cho, Sua
    Kim, Seunghwan
    Park, Sanghee
    Park, Taehyun
    Piccinini, Filippo
    Rhee, Won Jong
    Pyun, Jae-Chul
    Lee, Misu
    BMC CANCER, 2024, 24 (01)
  • [36] COMMD1, from the Repair of DNA Double Strand Breaks, to a Novel Anti-Cancer Therapeutic Target
    Suraweera, Amila
    Duijf, Pascal H. G.
    Jekimovs, Christian
    Schrobback, Karsten
    Liu, Cheng
    Adams, Mark N.
    O'Byrne, Kenneth J.
    Richard, Derek J.
    CANCERS, 2021, 13 (04) : 1 - 20
  • [37] Iron metabolism: an emerging therapeutic target underlying the anti-cancer effect of quercetin
    Yin, Mingming
    Liu, Yongping
    Chen, Yi
    FREE RADICAL RESEARCH, 2021, 55 (03) : 296 - 303
  • [38] NHE-1: A Promising Target for Novel Anti-cancer Therapeutics
    Loo, Ser Yue
    Chang, Michelle Ker Xing
    Chua, Charis Sui Huay
    Kumar, Alan Prem
    Pervaiz, Shazib
    Clement, Marie Veronique
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (10) : 1372 - 1382
  • [39] The potential of carbonic anhydrase enzymes as a novel target for anti-cancer treatment
    Zhou, Xiao-qun
    Ma, Xian-li
    Ariffin, Nur Syamimi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 976
  • [40] Cullin 7 in tumor development: a novel potential anti-cancer target
    Li, Yumiao
    Zang, Aiming
    Fu, Jiejun
    Jia, Youchao
    NEOPLASMA, 2021, 68 (03) : 572 - 579
12345